Antibiotic activity of isoxazolylnaphthoquinone imines on mice infected with Staphylococcus aureus.
The antibiotic activity of new synthetic isoxazolylnaphthoquinone imines was studied. Pseudomonas aeruginosa ATCC 27853 and Escherichia coli ATCC 25922 were resistant to the four compounds studied (MIC > 128 micrograms ml-1), but Staphylococcus aureus ATCC 25923, ATCC 29213 and 30 clinical isolates of Staph. aureus were inhibited by 2-hydroxy-N-(3,4-dimethyl-5-isoxazolyl)-1,4-naphthoquinone-4-imine (I). This compound diminished bloodstream infection of mice injected i.m. with Staph. aureus; septicaemia decayed significantly when I was applied at the beginning of the infection while when I was given 3 d after bacterial challenge, a significant protection was afforded. Bactericidal activity in serum increased during the 5 h after I was administered i.p. The acetyl derivative of I had a high MIC but when inoculated orally in mice decreased the Staph. aureus counts in circulation. This protection occurred only when the schedule of administration started close to the bacterial challenge. Antibiotic activity in vivo may be associated with in vitro effects.
Albesa
I
I
Departamento de Farmacia, Facultad de Ciencias et Químicas, Universidad Nacional de Córdoba, Argentina.
Bogdanov
P
P
Eraso
A
A
Sperandeo
N R
NR
de Bertorello
M M
MM
D000818:Animals; D000890:Anti-Infective Agents / Q000494:pharmacology / Q000627:therapeutic use*; D005260:Female; D007555:Isoxazoles / Q000494:pharmacology / Q000627:therapeutic use*; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D008826:Microbial Sensitivity Tests; D015394:Molecular Structure; D009284:Naphthols / Q000494:pharmacology / Q000627:therapeutic use*; D009285:Naphthoquinones; D013203:Staphylococcal Infections / Q000188:drug therapy* / Q000517:prevention & control
D000890:Anti-Infective Agents; D007555:Isoxazoles; D009284:Naphthols; D009285:Naphthoquinones; C070800:2-hydroxy-N-(3,4-dimethyl-5-isoxazolyl)-1,4-naphthoquinone imine